| Patient-derived precision cut tissue slices from primary liver cancer as a potential platform for preclinical drug testing R Jagatia, EJ Doornebal, U Rastovic, N Harris, M Feyide, AM Lyons, ... EBioMedicine 97, 2023 | 3 | 2023 |
| Human precision-cut liver slices: A potential platform to study alcohol-related liver disease U Rastovic, SF Bozzano, A Riva, A Simoni-Nieves, N Harris, R Miquel, ... International Journal of Molecular Sciences 25 (1), 150, 2023 | 1 | 2023 |
| THU-320-YI The pan-cyclophilin inhibitor rencofilstat exhibits therapeutic anti-fibrotic effects in human relevant models of alcohol-related liver disease via extracellular … U Rastovic, S Campinoti, L Wei, B Almeida, S Bozzano, R Amiri, N Harris, ... Journal of Hepatology 80, S128-S129, 2024 | | 2024 |
| Decellularised cell-derived matrix enables to study the extracellular matrix 3D remodelling in liver fibrosis and to evaluate therapy response L Wei, S Campinoti, B Almeida, U Rastovic, F Kenny, R Miquel, T Shaw, ... TISSUE ENGINEERING PART A 29 (13-14), 2023 | | 2023 |
| Hepatic stellate cell-derived extracellular matrix to model aetiology-and patient-specific matrix remodelling and fibrosis progression L Wei, S Campinoti, B Almeida, F Kenny, R Miquel, T Shaw, S Chokshi, ... Journal of Hepatology 78, S324, 2023 | | 2023 |
| Cyclophilin inhibition exhibits preventive and curative antifibrotic effects via extracellular matrix remodelling S Campinoti, U Rastovic, L Wei, N Harris, B Almeida, O Ajayi, C Kerins, ... Journal of Hepatology 78, S324, 2023 | | 2023 |
| Cyclophilin inhibitor Rencofilstat as a potential therapy for Alcohol-related Liver Disease E Palma, U Rastovic, S Campinoti, N Harris, O Ajayi, B Almeida, T Koay, ... ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 46, 87-87, 2022 | | 2022 |
| Cyclophilin inhibitor CRV431 as a potential therapy for alcohol-related liver disease E Palma, S Campinoti, U Rastovic, N Harris, TS Koay, L Ajayi, B Almeida, ... Journal of Hepatology 77, S120, 2022 | | 2022 |
| Dynamic organotypic culture of primary liver cancer as a personalised immunocompetent drug screening platform for immuno-oncology R Jagatia, E Doornebal, L Caciolli, N Harris, U Rastovic, S Campinoti, ... Journal of Hepatology 77 (S1), S389-S664, 2022 | | 2022 |
| Human Precision Cut Liver Slices as a model of Alcohol-related Liver Disease: recapitulating disease progression in a dish. E Palma, N Harris, U Rastovic, TS Koay, E Doornebal, S Phillips, A Riva, ... JOURNAL OF HEPATOLOGY 75, S321-S321, 2021 | | 2021 |
| Patient-Derived Precision Cut Tissue Slices from Primary Liver Cancer as a Suitable Platform for Preclinical Drug Testing EJ Doornebal, R Jagatia, U Rastovic, N Harris, A Martinez Lyons, ... | | |
Elena PalmaThe Roger Williams Institute of Hepatology, Foundation for Liver Research在 researchinliver.org.uk 的电子邮件经过验证
